首页> 外国专利> SYNTHESIS AND CHARACTERIZATION OF NOVEL DI-AZO CROSS-LINKED POLYMER FOR COLON SPECIFIC DELIVERY

SYNTHESIS AND CHARACTERIZATION OF NOVEL DI-AZO CROSS-LINKED POLYMER FOR COLON SPECIFIC DELIVERY

机译:新型结肠专用双偶氮交联聚合物的合成与表征

摘要

The aim of the current study was to synthesize di-azo polymers for colon targeted drug delivery and to characterize these polymers for the same. The novel azo crosslinking agents; diallyl ester of 4,4"-azobenzene dicarboxylic acid from p-Nitro benzoic acid & diallyl ester of 4,4"-azobenzene di-acetic acid from p-Nitro phenyl acetic acid were synthesized. These cross linkers were analyzed by spectral analysis like IR, Proton-NMR, GC-MS. Bulk polymerization method was used to synthesize azo polymers using different acrylate monomers viz. methyl methacrylate, butyl methacrylate. While synthesizing, the cross-linker concentration was varied. These di-azo polymers were characterized for organoleptic properties, solubility, film forming property, biodegradation study in rat caecal content, IR analysis. The polymers PMB 1:1:2:A and PMB 1:1:2:B were found to degrade completely in rat caecal content in anaerobic conditions only and further used to coat budesonide capsules. The drug release study revealed that the capsules coated with azo aromatic polymers PMB 1:1:2:A and PMB 1:1:2:B released 6.76% & 5.68% drug in pH 6.8 phosphate buffer respectively within 3 hrs. At the same time the release in media containing pH 6.8 phosphate buffer with 2% rat caecal content with anaerobic conditions was 36.98% and 25.03% drug within 3 hrs for polymer PMB 1:1:2:A and PMB 1:1:2:B respectively. There was significant (P=0.0269) (P 0.05) difference between cumulative percent drug release (within 3 hrs) in presence and absence of colonic contents. The drug release data was fitted to various kinetic models; results revealed that capsules coated with both co-polymers i.e. PMB 1:1:2:A and PMB 1:1:2:B shown higher correlation coefficient (R) values for zero order equation, indicating zero order release kinetics and the value of "n" was higher than 1.0 (n 1.0) indicating that, drug release occur by both diffusion of drug (non-fickian diffusion or super case II transport) & polymer degradation. This confirms the polymers releases drug only in presence of colonic contents in anaerobic conditions mainly due to azoreductase enzyme from colonic bacteria which cleaved azo bond in amines through amide intermediates. This gave finally bursting or erosion of polymer & release of drug in formulation.
机译:当前研究的目的是合成用于结肠靶向药物递送的二偶氮聚合物,并对其进行表征。新型偶氮交联剂;合成了对硝基苯甲酸的4,4“-偶氮苯二羧酸的二烯丙基酯和对硝基苯乙酸的4,4”-偶氮苯二乙酸的二烯丙基酯。这些交联剂通过诸如IR,质子NMR,GC-MS的光谱分析进行分析。本体聚合法被用于使用不同的丙烯酸酯单体来合成偶氮聚合物。甲基丙烯酸甲酯,甲基丙烯酸丁酯。在合成时,交联剂浓度是变化的。这些二偶氮聚合物具有感官特性,溶解性,成膜特性,大鼠盲肠含量的生物降解研究,IR分析等特性。发现仅在厌氧条件下,聚合物PMB 1:1:2:A和PMB 1:1:2:B完全在大鼠盲肠中降解,并进一步用于布地奈德胶囊的包衣。药物释放研究表明,涂有偶氮芳族聚合物PMB 1:1:2:A和PMB 1:1:2:B的胶囊在3小时内分别在pH 6.8磷酸盐缓冲液中释放了6.76%和5.68%的药物。同时,对于含聚合物PMB 1:1:2:A和PMB 1:1:2的聚合物,在3小时内,含有pH 6.8磷酸盐缓冲液且大鼠盲肠含量为2%的培养基中的释放为36.98%和25.03%的药物。 B分别。存在和不存在结肠内容物之间的累积药物释放百分比(3小时内)之间存在显着差异(P = 0.0269)(P <0.05)。药物释放数据适合各种动力学模型。结果表明,涂​​有两种共聚物(即PMB 1:1:2:A和PMB 1:1:2:B)的胶囊对于零阶方程显示出更高的相关系数(R)值,表明零阶释放动力学和β的值“ n”高于1.0(n> 1.0),这表明药物的释放是通过药物的扩散(非菲克扩散或超级案例II转运)和聚合物降解而发生的。这证实了该聚合物仅在厌氧条件下在结肠内容物存在时才释放药物,这主要是由于结肠细菌的偶氮还原酶通过酰胺中间体裂解了胺中的偶氮键所致。这最终使聚合物破裂或侵蚀,并释放制剂中的药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号